MyoKardia to Report First Quarter 2018 Financial Results on Tuesday, May 8, 2018
May 03, 2018 20:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 03, 2018 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Atomera Provides First Quarter 2018 Results
May 03, 2018 20:01 pm UTC| Business
LOS GATOS, Calif., May 03, 2018 -- Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor...
Inuvo Reports 19% Revenue Growth for the First Quarter 2018
May 03, 2018 20:01 pm UTC| Business
LITTLE ROCK, Ark., May 03, 2018 -- Inuvo, Inc. (NYSE American:INUV), an advertising technology company, today reported its financial results for the quarter ending March 31, 2018. Revenue for the 2018 first quarter...
Capital Southwest to Present at the East Coast IDEAS Investor Conference on May 10th in Boston
May 03, 2018 20:01 pm UTC| Business
DALLAS, May 03, 2018 -- Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq:CSWC), an internally managed business development company focused on providing flexible financing solutions to support...
Asterias Biotherapeutics to Report First Quarter 2018 Results on May 9, 2018
May 03, 2018 20:01 pm UTC| Business
FREMONT, Calif., May 03, 2018 -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination...
NV5 Announces Excellent First Quarter 2018 Results and Raises 2018 Guidance
May 03, 2018 20:01 pm UTC| Business
HOLLYWOOD, Fla., May 03, 2018 -- NV5 Global, Inc. (Nasdaq:NVEE) (“NV5” or the “Company”), a provider of professional and technical engineering and consulting solutions, today reported financial results for the first...
G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update
May 03, 2018 20:01 pm UTC| Business
U.S. and European regulatory meetings scheduled based on positive trilaciclib Phase 2a myelopreservation data Preliminary data from G1T38 Phase 1b trial in breast cancer to be presented at ASCO on June 2 Management to...